Sintilimab in Combination With Chidamide in Refractory and Relapsed AITL

Clinical trial NCT04831710 · UNKNOWN

Trial details

NCT number: NCT04831710
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Angioimmunoblastic T-cell Lymphoma

Start date: 2021-04-15
Primary completion: 2022-04-15
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.